SJ

Shil Jitendra Shah

Active Director Director DIN 02881764
DIN 02881764 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Feb 2010
Shareholding value •••• Premium profile

About Shil Jitendra Shah

Data last updated:

Shil Jitendra Shah is a Director at Umavida Pharma Private Limited (since 2019) and Director at Nibin Pharmaceuticals Private Limited (since 2010). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹24.56 Cr; the largest is Umavida Pharma Private Limited at ₹24.50 Cr (FY 2025). Earlier, Shil Jitendra Shah was a Director at Lakemedel Pharmaceuticals Private Limited (2014–2023).

DIN 02881764
Primary Designation Director
Industry Pharma
First Appointment 05 Feb 2010
Oldest Company Age 16 yrs
Largest company Umavida Pharma Private Limited · ₹24.50 Cr (FY 2025)
Combined revenue ₹24.56 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Umavida Pharma Private Limited U24299GJ2019PTC107172
Director20 Mar 20192019₹24.50 Cr (FY 2025)Active
Director05 Feb 20102010₹5.4 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Oct 20142014Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nibin Pharmaceuticals Private Limited
Umavida Pharma Private Limited
Lakemedel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shil Jitendra Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shil Jitendra Shah

Shil Jitendra Shah currently holds 2 directorships: Umavida Pharma Private Limited (Director, since 20 Mar 2019, revenue ₹24.50 Cr (FY 2025)); Nibin Pharmaceuticals Private Limited (Director, since 05 Feb 2010, revenue ₹5.4 Lakh (FY 2025)).

Shil Jitendra Shah was first appointed on 05 Feb 2010 as Director at Nibin Pharmaceuticals Private Limited. The most recent appointment on record is 20 Mar 2019 at Umavida Pharma Private Limited.

The 2 current companies of Shil Jitendra Shah that report revenue have a combined latest revenue of ₹24.56 Cr: Umavida Pharma Private Limited ₹24.50 Cr (FY 2025); Nibin Pharmaceuticals Private Limited ₹5.4 Lakh (FY 2025).

Shil Jitendra Shah held 1 earlier board appointment: Lakemedel Pharmaceuticals Private Limited (Director, 17 Oct 2014 to 27 Jul 2023).

The current boards of Shil Jitendra Shah's companies include Bindiya Rakesh Gohel (Umavida Pharma Private Limited), Fenil Jitendrakumar Shah (Umavida Pharma Private Limited), Jagdishbhai Bhagwatbhai Desai (Umavida Pharma Private Limited), Varun Hasmukh Patel (Umavida Pharma Private Limited), Vipul Raghunath Chaudhari (Umavida Pharma Private Limited), Jitendra Dasharathlal Shah (Nibin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available